Advertisement
Advanced searchCitation search
Skip main navigation
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement
No AccessJournal of UrologyOriginal Articles1 Jan 1980

Treatment of Recurrent Calcium Stone Formation with Cellulose Phosphate

    View All Author Information
    https://doi.org/10.1016/S0022-5347(17)55749-3

    Sodium cellulose phosphate was given to 35 patients for recurrent formation of calcium-containing stones. During therapy urinary calcium decreased by 40 per cent in the first month and remained at this lower level. In addition, urinary magnesium excretion was reduced and the urinary magnesium/calcium ratio remained unaffected. In these patients, who mostly had had calcium oxalate stones, the prophylactic effects of sodium cellulose phosphate was poor, with a 47 per cent recurrence rate after 2 years. This lack of prevention, despite the significant reduction of the urinary calcium, is assumed to be owing to the effects of treatment on magnesium and oxalate metabolism. Side effects were common, mainly consisting of moderate gastrointestinal discomfort, and caused withdrawal of treatment in 8 patients. This fact contributes further to our opinion that sodium cellulose phosphate is not the drug of choice in cases of calcium oxalate stone formation.

    © 1980 by The American Urological Association Education and Research, Inc.
    Copyright © 2025 American Urological Association Education and Research, Inc.

    COPYRIGHT AND PERMISSIONS: The Journal of Urology® is the Official Journal of the American Urological Association Education and Research, Inc. and is published monthly by Wolters Kluwer Health Inc. The American Urological Association grants the Publisher full and exclusive publishing and distribution rights, worldwide, for both print and electronic media. Therefore no portions of the work(s) can be reproduced without written consent from the Publisher. Permissions and photocopying: For permission and/or rights to use content for which the copyright holder is Wolters Kluwer or the society we have partnered with the Copyright Clearance Center to provide permissions for our products through their RightsLink service, please go to the journal's website and after clicking on the relevant article, click on the Get Content & Permissions link under the Article Tools box that appears on the right side of the page. For questions about the Rightslink service, e-mail [email protected] or call 877-622-5543 (U.S. Only) or 978-777-9929. Permissions FAQs and information on authors permission requests are available at Journal Permission.

    For translation rights requests, contact Translations. For license to republish and distribute requests, contact Licensing. For special projects and reprints (U.S./Canada), contact Alan Moore or [email protected]. For special projects and reprints (non-U.S./Canada), contact Avia Potashnik at [email protected] or [email protected].

    PRIVACY POLICY: This page is operated by Wolters Kluwer and is subject to Wolters Kluwer Privacy Policy.
    Your California Privacy Choicesopt-out icon